In hepatocellular carcinoma, miR-101 is proven to specifically bind to vascular endothelial growth factor (VEGF) mRNA three prime untranslated region (3′-UTR) to decrease protein levels of VEGFA (one of the main isotypes of VEGF) [21] and inhibit VEGFR2 signaling pathway thereby impair the malignant behavior of HCC cells. The gene discussed is VEGFA; the disease is hepatocellular carcinoma.